PRESS RELEASE published on 07/03/2026 at 07:00, 2 months 20 days ago Informations privilégiées / Autres communiqués Median Technologies obtient le marquage CE pour eyonis® LCS, logiciel IA pour dépistage cancer du poumon, en Europe. eyonis® LCS offre performances uniques pour diagnostic précoce Marquage CE Dépistage Median Technologies Cancer Du Poumon Eyonis® LCS
PRESS RELEASE published on 07/03/2026 at 07:00, 2 months 20 days ago Inside Information / Other news releases Median Technologies' eyonis® LCS obtains CE Marking under new European Medical Device Regulation, enabling commercial launch across the EU. AI-based software empowers lung cancer screening programs for earlier diagnosis Median Technologies CE Marking AI-based Software Lung Cancer Screening Eyonis® LCS
BRIEF published on 06/03/2026 at 19:59, 3 months 20 days ago Median Technologies Raises €50 Million in Capital Increase Capital Increase Shareholder Base Market Oversubscription Eyonis® Deployment AI-based Diagnostics
BRIEF published on 06/03/2026 at 19:59, 3 months 20 days ago Median Technologies lève 50 millions d'euros lors d'une augmentation de capital Augmentation De Capital Diagnostics Basés Sur L'IA Base D'actionnaires Sursouscription Du Marché Déploiement Eyonis®
PRESS RELEASE published on 06/03/2026 at 19:54, 3 months 20 days ago Informations privilégiées / Autres communiqués Median Technologies annonce le vif succès de son augmentation de capital de 50 millions d'euros. Opération sursouscrite, soutien du marché fort, déploiement commercial d'eyonis® LCS et nouvelles indications cliniques Investisseurs Institutionnels Augmentation De Capital Median Technologies Diagnostic Précoce Eyonis® LCS
PRESS RELEASE published on 06/03/2026 at 19:54, 3 months 20 days ago Inside Information / Other news releases Median Technologies successfully completes €50 million capital increase without shareholders' preferential subscription rights. Funds to deploy eyonis® LCS in U.S. and Europe and expand clinical indications Investment Capital Increase Median Technologies Eyonis® LCS Clinical Indications
BRIEF published on 05/21/2026 at 17:50, 4 months 2 days ago Median Technologies Publishes Shareholder Meeting Documents Voting Rights Shareholders’ Meeting Euronext Growth Median Technologies Documents Availability
BRIEF published on 05/21/2026 at 17:50, 4 months 2 days ago Median Technologies publie les documents de l'assemblée générale des actionnaires Droit De Vote Euronext Croissance Assemblée Générale Des Actionnaires Technologies Médianes Disponibilité Des Documents
PRESS RELEASE published on 05/21/2026 at 17:45, 4 months 2 days ago Terms of availability of the information and the report on corporate governance Median Technologies releases preparatory documents for the Annual Shareholders’ Meeting on June 10, 2026. Shareholders can access documents on the company's website Shareholders General Meeting Annual Shareholders’ Meeting Preparatory Documents Median Technologies
BRIEF published on 03/30/2026 at 15:19, 5 months 24 days ago Median Technologies obtient la certification ISO 13485:2016 ISO 13485:2016 Normes Réglementaires Logiciel Basé Sur L'IA Solutions En Oncologie Eyonis®
Published on 09/23/2026 at 22:00, 2 hours 48 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 6 hours 23 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 9 hours 6 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 10 hours 17 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 10 hours 18 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/23/2026 at 23:00, 1 hour 48 minutes ago Correction d’un communiqué du 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION AINSI QU’UN REMBOURSEMENT PARTIEL D’OBLIGATIONS REMBOURSABLES EN ACTIONS
Published on 09/23/2026 at 23:00, 1 hour 48 minutes ago Correction of a release from 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION RIGHTS AND THE PARTIAL EARLY REDEMPTION OF BONDS REDEEMABLE IN SHARES
Published on 09/23/2026 at 19:51, 4 hours 57 minutes ago LIGHTON: LightOn renouvelle son financement obligataire auprès des mêmes partenaires financiers pour un montant nominal maximum de 4 millions d’euros, et étend ainsi son horizon de trésorerie
Published on 09/23/2026 at 19:51, 4 hours 57 minutes ago LIGHTON: LightOn renews its bond financing with the same financial partners for a maximum nominal amount of €4 million, and thus extends its cash flow horizon
Published on 09/23/2026 at 19:30, 5 hours 18 minutes ago EUROPLASMA: Valdunes Industries et Saarstahl Ascoval s’associent pour développer une nouvelle génération de « roues vertes »
Published on 09/23/2026 at 19:46, 5 hours 2 minutes ago SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 5 hours 34 minutes ago Robust performance from Investments and continued execution of the strategy
Published on 09/23/2026 at 19:14, 5 hours 34 minutes ago Performance robuste des Investissements, poursuite du déploiement de la stratégie
